Last reviewed · How we verify
NCT05325606: RAV-TUN
Registry-based Stroke in Tunisia
trial in Stroke, Ischemic in 800 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | University of Monastir |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 800 |
| Start date | 1 June 2020 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Tunisia |
Conditions studied
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
- Strokes Thrombotic — all drugs for Strokes Thrombotic →
- Stroke — all drugs for Stroke →
Sponsor
University of Monastir
Who can join
Adults 18 to 99, any sex, with Stroke, Ischemic or Strokes Thrombotic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study the prevalence of strokes in the emergency department (ED) and their possible eligibility for thrombolysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05325606
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Ischemic
Currently open trials in the same condition.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
- NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
- NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting
Other University of Monastir trials
Trials by the same sponsor.
- NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
- NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
- NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
- NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
- NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05325606 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Monastir
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05325606.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing